/PRNewswire/ The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna.
Kyverna Therapeutics (NASDAQ:KYTX) Sets New 1-Year Low at $11.75 modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Kyverna Therapeutics (NASDAQ:KYTX) Shares Down 3.7% wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Kyverna Therapeutics (NASDAQ:KYTX) Reaches New 12-Month Low at $12.16 modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.